This side of phase 2 results there is still a large risk here and big pharma know that. Most phase 2 trials fail and its a risk that we can't control. - either the science will be there or it wont. What we can do is mitagate the risk by take measured steps forward and validating before continued investment. Something the management team has done a superb job of. That and doing 'good research' and 'good IP protection' and we have research and business sides ticked. And so far the science is stacking up.
Good luck for the longs on positive phase 2 results to derisk this baby for big pharma imgagin 2. Deals to flow....
A little spoken of recutement along with Vince.... Howie McKibbon.
We are in good hands fokes - steady ship heading to the new world! Maybe we will drop off the edge of this flat earth or maybe well find unexplored spoils.
Bot Chart, page-578
-
- There are more pages in this discussion • 13,172 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.055(16.9%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 38.0¢ | 33.0¢ | $7.103M | 19.63M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 134000 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 650314 | 19 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |